News
Emblation Appoints Medical Affairs Advisors
6 October 2026
/ News
Experienced Clinicians Will Strengthen the Company’s Peer–to-Peer Educational Support
Swift microwave treatment featured in The Mail on Sunday
29 September 2026
/ News
Emblation’s Swift microwave treatment has been featured in The Mail on Sunday in an article examining its potential to tackle stubborn and long-standing verrucas.
Emblation Recognizes July as Wart Awareness Month with New Summer Campaign
22 July 2026
/ News
Emblation, the company behind the innovative Swift microwave therapy system, recognizes July Wart Awareness Month, an initiative aimed at educating the public on preventing warts.
Emblation Announces Strategic Partnership with DermLite to Assist Diagnosis and Documentation of Skin Conditions Treated by Swift Technology
4 June 2026
/ News
Enhanced dermoscopy access now available for clinicians who are using the Swiftscope app.
Emblation Launches Swiftscope App for Enhanced Visual Monitoring of SwiftPro Treatments
26 May 2026
/ News
New app integrates with smartphone dermatoscopes to provide clinicians with side-by-side treatment tracking and improved patient education.
Emblation Secures FDA 510(k) Clearance for Swift™ & SwiftPro™ Systems in Treatment of Common and Plantar Warts
18 December 2025
/ News
Microwave therapy is proven to be the smarter, safer, less painful choice for wart treatment across the US and UK.
A Revolution In Corn Pain
26 November 2024
/ News
A BREAKTHROUGH in treating painful corns that blight the lives of millions of people has been credited to Emblation’s Swift device.
